And they haven't been proven wrong,
As for a potential CR , It may or may not happen depends on partnerships. Important to remember however that partnerships are usually a form of CR anyway , most of us would love to see a partnership and personally I think at least one more is most likely.
It is also quite possible that we are only a month or so away from been commercially sustainable through GVHD and- or ARDS.
So even if a CR is required ( not bad , always well supported and gives great returns for current SH in the form of progress) it won't be happening till after the ARDS read out and confirmation of the Novartis deal.
Good luck all.
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-567
-
- There are more pages in this discussion • 537 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.045(3.50%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.35 | $1.30 | $2.885M | 2.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 7070 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |